GlaxoSmithKline has set a target to cut by two-thirds the waste generated by medicines production from levels that until recently required 100kg of raw materials for every 1kg of drug produced.
The UK-based pharmaceutical group aims by 2015 to cut waste in its factories around the world to 30kg for each 1kg of "active pharmaceutical ingredient" (API), compared with an average of 100kg in 2005.
